A Leading Recruiter In Finding the Industry’s Best Pharma Jobs – Lucas Group #pharma #research

Posted On Nov 17 2017 by

#pharmaceutical recruiters # A Leading Recruiter In Finding the Industry’s Best Pharma Jobs One of the largest and most crucial sectors of our economy, the pharmaceutical industry, is undergoing many changes and exponential growth. As new drugs are developed, manufactured and introduced in the market, the need for skilled professionals to lead these initiatives continues to increase. In this rapidly evolving industry, manufacturers are looking for exceptional talent to fill critical pharma jobs and drive business goals and strategies. Now more than ever, manufacturers realize the importance of finding and retaining the best of the best to achieve maximum success. …


Global pharmaceutical industry is in a strategic crisis – Business models must be adjusted #pharmaceutical #market #analysis

Posted On Nov 16 2017 by

#global pharmaceutical industry # Munich, January 06, 2013 Global pharmaceutical industry is in a strategic crisis – Business models must be adjusted Three out of four pharmaceutical companies are convinced their industry is in the midst of a strategic crisis Price and cost pressure, regulatory changes and expiring patents are leading to shrinking margins Emerging markets offer the biggest growth opportunities for the pharmaceutical industry – Their market share is set to rise to almost 40% by 2016, albeit with smaller margins Pharmaceutical companies are prepared to relocate their administration (44%), R D (43%) and sales departments (51%) to emerging …


Elite Pharmaceuticals and Epic Pharma Enter Into a Sales and Distribution Licensing Agreement for Abuse-Deterrent ELI-200 Other OTC: ELTP #ono #pharma

Posted On Nov 15 2017 by

#epic pharma # Elite Pharmaceuticals and Epic Pharma Enter Into a Sales and Distribution Licensing Agreement for Abuse-Deterrent ELI-200 June 09, 2015 08:00 ET | Source: Elite Pharmaceuticals, Inc. NORTHVALE, N.J. June 9, 2015 (GLOBE NEWSWIRE) — Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCQB:ELTP) announced today that it has entered into a sales and distribution licensing agreement with Epic Pharma LLC for ELI-200 (the “License”), an abuse-deterrent opioid utilizing Elite’s proprietary pharmacological abuse-deterrent technology. Epic will be responsible for sales and marketing of ELI-200, and Elite will be responsible for the manufacture of the product. Epic will pay Elite …


Ajanta Pharma A Dose Of Strong Medicine – BW Businessworld #www.pharma.com

Posted On Nov 13 2017 by

#ajanta pharma # Ajanta Pharma: A Dose Of Strong Medicine The Agrawal brothers of Ajanta Pharma — Yogesh and Rajesh — travelled to at least 100 countries and scoured India to learn the ropes of the speciality pharmaceutical market when they joined their ailing family business almost 15 years ago. Saddled with huge debt and declining growth, they were tasked with doing something urgently to save the business and also with learning what not to do. The US-educated sons of founder-promoter Mannalal Agrawal began by deciding to undo several things that the 40-year-old company had been doing. Ajanta was manufacturing …


PCAB – A Service of ACHC #dusa #pharma

Posted On Nov 12 2017 by

#pharmacies # PCAB: A Service of ACHC Established by eight of the nation’s leading pharmacy organizations in 2007, Pharmacy Compounding Accreditation Board (PCAB) based on (USP) 1 United States Pharmacopeial Convention standards, offers the most comprehensive compliance solution in the industry. PCAB accreditation in combination with the pharmacy’s commitment to continuous compliance significantly reduces the risk associated with compounding medications. PCAB: Compounding Accreditation Many physicians recognize PCAB Accreditation as a benchmark of quality and refer patients to PCAB Accredited pharmacies. PCAB Accreditation serves as a distinction for compounding pharmacies by demonstrating a commitment to providing high quality compounded medications. PCAB …


The Top 10 Myths About Selecting a Contract Manufacturing Partner #novartis #pharma

Posted On Nov 10 2017 by

#contract manufacturing # The Top 10 Myths About Selecting a Contract Manufacturing Partner With so much of today s electronics manufacturing outsourced, my team at Riverwood Solutions ends up spending a lot of time inside various contract manufacturing facilities. Sitting on a plane today heading to yet another contract manufacturing (CM) visit, I started tallying the number of CM factories, and the number of different countries my team has been in over the past year visiting CMs. I was able to quickly rattle off CM factories in 24 different countries on 5 continents that were visited by just the consulting …


A Must-Read Overview of the US Biotechnology Industry – Market Realist #pharmaceutical #company #names

Posted On Nov 10 2017 by

#biotechnology industry # A Must-Read Overview of the US Biotechnology Industry The above graph shows the breakdown of total revenues that biotechnology companies (IBB ) earn in the various disciplines. Biopharmaceuticals are drugs developed from biological sources and used to treat animal and human diseases. They account for about a third of total revenues, or $150 billion, earned by the biotechnology sector in 2014. Biotech seeds, or genetically modified food, is the cross discipline between biotechnology and agriculture. Industrial biotechnology includes all other applications of biotechnology in sectors like chemicals, biofuels, feedstock, and energy. Biopharmaceuticals Biopharmaceutical companies such as Amgen …


Advancing a Pharmaceutical Business Plan with an Investor Perception Study – FTI Strategic Communications #pharma #validation

Posted On Nov 10 2017 by

#pharmaceutical business plan # Advancing a Pharmaceutical Business Plan with an Investor Perception Study Sagent Pharmaceuticals (Sagent) enlisted FTI to execute a hybrid perception study to gather investor intelligence pertaining to the company’s long-term strategic plan and its recent acquisition of a facility in China through both in-depth interviews and an online survey. In-Depth Research. FTI spoke with 40 members of the investment community, including both current and past institutional investors, as well as key covering analysts of the equity research universe. Through both individual conversations and survey results, FTI assessed reaction and viewpoints on a variety of topics specific …